A look at breakthrough treatment for sickle cell anemia
A cutting-edge gene therapy is offering new hope in combating the painful disease that afflicts about 100,000 Americans, many of whom are Black.
A cutting-edge gene therapy is offering new hope in combating the painful disease that afflicts about 100,000 Americans, many of whom are Black.
The Michigan Daily spent 24 hours on the Diag to document day-to-day operations of the UMich student-organized Gaza solidarity encampment.
The therapeutic arsenal for the management of AML has expanded significantly in recent years. Before 2017, newly diagnosed AML was treated with either standard cytarabine-…
Enfortumab vedotin/pembrolizumab, gemcitabine-cisplatin/nivolumab, and the JAVELIN paradigm can all play a role as first-line therapy for appropriately selected patients with advanced urothelial carcinoma.
Cigna tracks every minute that its staff doctors spend deciding whether to pay for health care. Dr. Debby Day said her bosses cared more about…
Multiple myeloma, a plasma-cell neoplasm characterized by skeletal destruction, renal failure, anemia, and hypercalcemia, remains incurable. However, recent advances in its treatment, in particular…
Medical Oncology – Cancer patients receiving chemotherapy are prone to develop infections that might postpone treatment and lead to complications. The aim of our study…
Patients with plateau-phase multiple myeloma have an increased risk of life-threatening bacterial infections and polyclonal humoral immune suppression. We conducted a randomised, double-blind, placebo-controlled, multicentre…
Pneumococcal vaccination: the response of patients with multiple myeloma
Open access journal of the Ferrata-Storti Foundation, a non-profit organization Open access journal of the Ferrata-Storti Foundation, a non-profit organization State Key Laboratory of Experimental…
The OncoAlert Newsletter is now out for June 23-29, 2023